Activation of NFATc1 is directly mediated by IP 3 in adult cardiac myocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 5, 2010, Pages

  Rinne, Andreas ^a   Blatter, Lothar A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adult myocytes; Endothelin 1; Inositol 1,4,5 trisphosphate; Nuclear factor of activated T cells

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; INOSITOL 1,4,5 TRISPHOSPHATASE; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT3;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CELL MEMBRANE PERMEABILITY; CYTOPLASM; ENZYME BLOOD LEVEL; HEART BEAT; HEART DEVELOPMENT; HEART MUSCLE CELL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANIMALS; CALCIUM; CELLS, CULTURED; ENDOTHELIN-1; FEMALE; GREEN FLUORESCENT PROTEINS; INOSITOL 1,4,5-TRISPHOSPHATE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MODELS, ANIMAL; MYOCYTES, CARDIAC; NFATC TRANSCRIPTION FACTORS; PHENYLEPHRINE; RABBITS; SIGNAL TRANSDUCTION;

EID: 78249248068     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00470.2010     Document Type: Article

References (38)

1. Bers DM. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 70: 23-49, 2008.
2. Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell 109, Suppl: S67-S79, 2002.
3. de la Pompa JL, Timmerman LA, Takimoto H, Yoshida H, Elia AJ, Samper E, Potter J, Wakeham A, Marengere L, Langille BL, Crabtree GR, Mak TW. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392: 182-186, 1998. (Pubitemid 28162791)
4. Dean DA, Urban G, Aragon IV, Swingle M, Miller B, Rusconi S, Bueno M, Dean NM, Honkanen RE. Serine/threonine protein phosphatase 5 (PP5) participates in the regulation of glucocorticoid receptor nucleocytoplasmic shuttling. BMC Cell Biol 2: 6, 2001. (Pubitemid 38597719)
5. 2+ response amplitude and duration. Nature 386: 855-858, 1997.
6. 2+ release termination by ryanodine receptor sensitization and in heart failure. J Physiol 587: 5197-5209, 2009.
7. 2+ release modulates excitation-contraction coupling in rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol 294: H596-H604, 2008.
8. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, Hogan PG, Lewis RS, Daly M, Rao A. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441: 179-185, 2006.
9. Fitzgerald DJ, Burgoyne RD, Haynes LP. Neuronal calcium sensor proteins are unable to modulate NFAT activation in mammalian cells. Biochim Biophys Acta 1780: 240-248, 2008.
10. 2+-dependent NFATc3 nuclear accumulation in vascular smooth muscle: role of JNK2 and Crm-1. J Biol Chem 278: 46847-46853, 2003.
11. Graef IA, Chen F, Crabtree GR. NFAT signaling in vertebrate development. Curr Opin Genet Dev 11: 505-512, 2001.
12. 2+ entry and NFAT activation in lymphocytes. Cell Calcium 42: 145-156, 2007.
13. 2+ release is a nexus for hypertrophic signaling in cardiac myocytes. Mol Cell 33: 472-482, 2009.
14. Kehlenbach RH, Dickmanns A, Gerace L. Nucleocytoplasmic shuttling factors including Ran and CRM1 mediate nuclear export of NFAT In vitro. J Cell Biol 141: 863-874, 1998. (Pubitemid 28243955)
15. Kockskamper J, Zima AV, Roderick HL, Pieske B, Blatter LA, Bootman MD. Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes. J Mol Cell Cardiol 45: 128-147, 2008.
16. Kuwahara K, Wang Y, McAnally J, Richardson JA, Bassel-Duby R, Hill JA, Olson EN. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Invest 116: 3114-3126, 2006.
17. 3)-receptor type 2-deficient mice. Circ Res 96: 1274-1281, 2005.
18. MacDonnell SM, Weisser-Thomas J, Kubo H, Hanscome M, Liu Q, Jaleel N, Berretta R, Chen X, Brown JH, Sabri AK, Molkentin JD, Houser SR. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes. Circ Res 105: 316-325, 2009.
19. Mende U, Kagen A, Cohen A, Aramburu J, Schoen FJ, Neer EJ. Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci USA 95: 13893-13898, 1998.
20. 2+ in the heart: contraction versus intracellular signaling. J Clin Invest 116: 623-626, 2006.
21. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228, 1998. (Pubitemid 28180855)
22. 3 receptor regulates cardiac hypertrophy in response to select stimuli. Circ Res 107: 659-666, 2010.
23. Ohba T, Watanabe H, Murakami M, Takahashi Y, Iino K, Kuromitsu S, Mori Y, Ono K, Iijima T, Ito H. Upregulation of TRPC1 in the development of cardiac hypertrophy. J Mol Cell Cardiol 42: 498-507, 2007.
24. Qi XY, Yeh YH, Xiao L, Burstein B, Maguy A, Chartier D, Villeneuve LR, Brundel BJ, Dobrev D, Nattel S. Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current. Circ Res 103: 845-854, 2008.
25. Rao A. Signaling to gene expression: calcium, calcineurin and NFAT. Nat Immunol 10: 3-5, 2009.
26. Rinne A, Banach K, Blatter LA. Regulation of nuclear factor of activated T cells (NFAT) in vascular endothelial cells. J Mol Cell Cardiol 47: 400-410, 2009.
27. Rinne A, Blatter LA. A fluorescence-based assay to monitor transcriptional activity of NFAT in living cells. J Physiol 588: 3211-3216, 2010.
28. 2+-sensitive transcription factor NFAT in cardiac myocytes and in heart failure. Am J Physiol Heart Circ Physiol 298: H2001-H2009, 2010.
29. Shen T, Liu Y, Cseresnyes Z, Hawkins A, Randall WR, Schneider MF. Activity- and calcineurin-independent nuclear shuttling of NFATc1, but not NFATc3, in adult skeletal muscle fibers. Mol Biol Cell 17: 1570-1582, 2006.
30. Voigt N, Maguy A, Yeh YH, Qi X, Ravens U, Dobrev D, Nattel S. Changes in IK,ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. Cardiovasc Res 77: 35-43, 2008.
31. Wilkins BJ, Molkentin JD. Calcineurin and cardiac hypertrophy: where have we been? Where are we going? J Physiol 541: 1-8, 2002.
32. Wilkins BJ, Molkentin JD. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 322: 1178-1191, 2004. (Pubitemid 39164648)
33. Wu H, Peisley A, Graef IA, Crabtree GR. NFAT signaling and the invention of vertebrates. Trends Cell Biol 17: 251-260, 2007.
34. Wu X, Eder P, Chang B, Molkentin JD. TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Proc Natl Acad Sci USA 107: 7000-7005, 2010.
35. 2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest 116: 675-682, 2006.
36. Xiao L, Coutu P, Villeneuve LR, Tadevosyan A, Maguy A, Le Bouter S, Allen BG, Nattel S. Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes. Circ Res 103: 733-742, 2008.
37. 2+ signalling in the mammalian heart. J Physiol 584: 601-611, 2007.
38. 2+ signalling in cat atrial excitation-contraction coupling and arrhythmias. J Physiol 555: 607-615, 2004.